Robert Letterio Oliva, Director at Novo Integrated Sciences, Inc. (NVOS), bought 9,555 shares at $4.31 ($41K) on 2021-02-22, disclosed to the SEC on 2021-02-23.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $4.31 | 9,355 | $40K | 97.8% |
| 2 | $4.45 | 200 | $890 | 2.2% |
| Total | $4.31 avg | 9,555 | $41K | 100% |
| Filing → |